Table 1.
Patient characteristics.
Age | Number of Patients | |
49–59 | 4 | |
60–69 | 22 | |
70–80 | 27 | |
Median Age (range) | 70 years (49 – 80) | |
T stage | ||
T1b | 1 | |
T1c | 21 | |
T2a | 9 | |
T2b,c | 13 | |
T3a,b | 7 | |
T4 | 2 | |
Gleason Score | ||
3 + 3 | 1 | |
3 + 4 and 4 + 3 | 14 | |
3 + 5 | 1 | |
4 + 4 | 12 | |
4 + 5 and 5 + 4 | 24 | |
5 + 5 | 1 | |
PSA at Diagnosis | ||
≤10 | 18 | |
10.1 – 20 | 13 | |
>20 | 22 | |
Median PSA (range) | 15.4 ng/mL (1.6 – 150.2) | |
N Stage | ||
pN1 | 1 | |
cN1 (radiographic) | 3 | |
cN0 | 49 | |
Androgen Deprivation median duration(range) | 12 months (0 – 28) | |
Duration (mo.) | # pts | |
0 | 3 | |
3 – 4 | 3 | |
6–12 | 37 | |
15–24 | 7 | |
25 – 28 | 3
|
|
53 | ||
Median Pretreatment IPSS Score (range) | 11 (0 – 27) |